What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?-Reference-Cited by-同舟云学术

What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?

Published:2011-03-15 Issue:6 Volume:14 Page:1167-1172
ISSN:1523-0864
Container-title:Antioxidants & Redox Signaling
language:en
Short-container-title:Antioxidants & Redox Signaling

Author:

D'Adamo Ebe¹²,Giannini Cosimo¹²,Chiavaroli Valentina¹,de Giorgis Tommaso¹,Verrotti Alberto¹,Chiarelli Francesco¹²,Mohn Angelika¹²

Affiliation:

1. Department of Pediatrics, University of Chieti, Chieti, Italy.

2. Center of Excellence on Aging, “G. D'Annunzio” University Foundation, University of Chieti, Chieti, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry,Cell Biology,Clinical Biochemistry,Molecular Biology,Physiology,Biochemistry

Link

http://www.liebertpub.com/doi/pdf/10.1089/ars.2010.3719

Reference24 articles.

1. Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH)

2. 2. Altman DG.Practical Statistics for Medical Research. London: Chapman & Hall, 1991, pp. 431–433.

3. Alanine Aminotransferase Levels and Fatty Liver in Childhood Obesity: Associations with Insulin Resistance, Adiponectin, and Visceral Fat

4. Glucose dysregulation and hepatic steatosis in obese adolescents: Is there a link?

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study;Frontiers in Endocrinology;2023-08-11

2. Blood and Tissue Advanced Glycation End Products as Determinants of Cardiometabolic Disorders Focusing on Human Studies;Nutrients;2023-04-21

3. Receptor soluble para productos finales de glicación avanzada y perfil lipídico como marcadores de riesgo cardiovascular en niños con obesidad;Gaceta Médica de México;2023-02-09

4. Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review;Gastroenterology Review;2023

5. Soluble receptor for advanced glycation end-products (sRAGE) in childhood obesity: association with gene expression of RAGE and cardiometabolic markers;Nutrición Hospitalaria;2023